Literature DB >> 1283186

Compliance and the benefit/risk relationship of antihypertensive treatment.

J Hasford1.   

Abstract

Compliance is defined as a patient's behavior in terms of taking prescribed medication, following diets, or executing medically recommended lifestyle changes. Furthermore, compliance measures the extent to which a person's behavior coincides with medical or health advice. The measurement of compliance over time is still a problem. The recently developed medication monitors, however, enable precise documentation of the taking of pills out of the container over long time periods. Long-term compliance with antihypertensive treatments is, referring to the literature, about 50%. The causes of partial compliance are not yet well known. Partial compliance is often accompanied by reduced benefit, e.g., poor blood pressure control. There are even strong arguments that partial compliance increases the risks of treatment, especially with beta-blockers. Thus, the traditional physicians' nonperception of patients' partial compliance is no longer acceptable, as partial compliance has a negative impact on the benefit/risk ratio.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283186

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Antihypertensive treatment, compliance, and quality of life: Review of a little-understood relation.

Authors:  R Weitkunat; H Rau; S Brody
Journal:  J Clin Psychol Med Settings       Date:  1995-06

Review 2.  Sudden cardiac death in patients with hypertension. An association with diuretics and beta-blockers?

Authors:  A W Hoes; D E Grobbee; J Lubsen
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

3.  The determinants of hypertension awareness, treatment, and control in an insured population.

Authors:  D H Stockwell; S Madhavan; H Cohen; G Gibson; M H Alderman
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

4.  Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study.

Authors:  S I Sjahid; P D van der Linden; B H Stricker
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.